神州數碼(000034.SZ):希格瑪擬協議轉讓3350萬股
格隆匯12月18日丨神州數碼(000034.SZ)公佈,近日公司收到公司股東中國希格瑪有限公司通知,獲悉其與中國新紀元有限公司於2024年12月17日簽署了《股份轉讓協議》,希格瑪擬通過協議轉讓的方式向新紀元轉讓其持有的公司股份合計33,500,000股無限售流通股,佔公司總股本的5.00%,佔公司剔除回購賬户股份後總股本的5.04%,轉讓價格為30.11元/股,轉讓價款合計人民幣100,868.50元。上述交易如最終能順利實施,新紀元將成為公司5%以上股東。本次股份轉讓後,希格瑪持有公司股票14,293,415股,佔公司剔除回購賬户股份後總股本的2.15%,新紀元將持有公司股票33,500,000股,佔公司剔除回購賬户股份後總股本的5.04%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.